AdaptHealth (AHCO) Net Income towards Common Stockholders (2018 - 2026)

AdaptHealth's Net Income towards Common Stockholders history runs 9 years deep, the most recent figure standing at -$14.9 million for Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders fell 144.66% year-over-year to -$14.9 million in Q1 2026; TTM through Mar 2026 was -$74.9 million, a 183.33% decrease from a year earlier, with the FY2025 full-year figure at -$66.1 million, down 169.66% from the prior year.
• Net Income towards Common Stockholders advanced to -$14.9 million in Q1 2026 per AHCO's latest filing, from -$101.6 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $51.4 million in Q4 2024 and bottomed at -$452.9 million in Q3 2023.
• The 5-year median for Net Income towards Common Stockholders is $14.8 million (2022), against an average of -$35.1 million.
• Across the five-year window, Net Income towards Common Stockholders surged 1063.51% in 2022 and slumped 15381.01% in 2023, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$1.6 million in 2022, then slumped by 15381.01% to -$253.6 million in 2023, then soared by 120.27% to $51.4 million in 2024, then sank by 297.61% to -$101.6 million in 2025, then soared by 85.36% to -$14.9 million in 2026.
• Per Business Quant, the three latest AHCO Net Income towards Common Stockholders figures stand at -$14.9 million (Q1 2026), -$101.6 million (Q4 2025), and $25.8 million (Q3 2025).